These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9295235)

  • 1. Actions of two highly potent organophosphorus neuropathy target esterase inhibitors in mammalian cell lines.
    Li W; Casida JE
    Toxicol Lett; 1997 Jul; 92(2):123-30. PubMed ID: 9295235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subacute neurotoxicity induced in mice by potent organophosphorus neuropathy target esterase inhibitors.
    Wu SY; Casida JE
    Toxicol Appl Pharmacol; 1996 Jul; 139(1):195-202. PubMed ID: 8685903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organophosphorus neuropathy target esterase inhibitors selectively block outgrowth of neurite-like and cell processes in cultured cells.
    Li W; Casida JE
    Toxicol Lett; 1998 Sep; 98(3):139-46. PubMed ID: 9788582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathy target esterase of hen brain: active site reactions with 2-[octyl-3H]octyl-4H-1,3,2-benzodioxaphosphorin 2-oxide and 2-octyl-4H-1,3,2-[aryl-3H]benzodioxaphosphorin 2-oxide.
    Yoshida M; Tomizawa M; Wu SY; Quistad GB; Casida JE
    J Neurochem; 1995 Apr; 64(4):1680-7. PubMed ID: 7891095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethyl octylphosphonofluoridate and analogs: optimized inhibitors of neuropathy target esterase.
    Wu SY; Casida JE
    Chem Res Toxicol; 1995 Dec; 8(8):1070-5. PubMed ID: 8605290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophospholipase inhibition by organophosphorus toxicants.
    Quistad GB; Casida JE
    Toxicol Appl Pharmacol; 2004 May; 196(3):319-26. PubMed ID: 15094302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylcholinesterase and neuropathy target esterase inhibitions in neuroblastoma cells to distinguish organophosphorus compounds causing acute and delayed neurotoxicity.
    Ehrich M; Correll L; Veronesi B
    Fundam Appl Toxicol; 1997 Jul; 38(1):55-63. PubMed ID: 9268605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivity and stereospecificity of neuropathy target esterase and alpha-chymotrypsin with 2-substituted-4H-1,3,2-benzodioxaphosphorin 2-oxides.
    Yoshida M; Wu SY; Casida JE
    Toxicol Lett; 1994 Nov; 74(2):167-76. PubMed ID: 7940598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of [3H]octylphosphonyl-labeled neuropathy target esterase by chicken nervous tissue autoradiography.
    Kamijima M; Casida JE
    Neurosci Lett; 1999 Oct; 273(2):101-4. PubMed ID: 10505626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathy target esterase in mouse whole blood as a biomarker of exposure to neuropathic organophosphorus compounds.
    Makhaeva GF; Rudakova EV; Sigolaeva LV; Kurochkin IN; Richardson RJ
    J Appl Toxicol; 2016 Nov; 36(11):1468-75. PubMed ID: 26970094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy.
    Lotti M; Moretto A; Capodicasa E; Bertolazzi M; Peraica M; Scapellato ML
    Toxicol Appl Pharmacol; 1993 Oct; 122(2):165-71. PubMed ID: 8211998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity.
    Winrow CJ; Hemming ML; Allen DM; Quistad GB; Casida JE; Barlow C
    Nat Genet; 2003 Apr; 33(4):477-85. PubMed ID: 12640454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibitors of fatty acid amide hydrolase relative to neuropathy target esterase and acetylcholinesterase: toxicological implications.
    Quistad GB; Sparks SE; Segall Y; Nomura DK; Casida JE
    Toxicol Appl Pharmacol; 2002 Feb; 179(1):57-63. PubMed ID: 11884237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies of O,O-dialkyl-O-chloromethylchloroformimino phosphates: interaction with neuropathy target esterase and acetylcholinesterase.
    Makhaeva GF; Filonenko IV; Yankovskaya VL; Fomicheva SB; Malygin VV
    Neurotoxicology; 1998; 19(4-5):623-8. PubMed ID: 9745921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathy target esterase (NTE) and organophosphorus-induced delayed polyneuropathy (OPIDP): recent advances.
    Johnson MK; Glynn P
    Toxicol Lett; 1995 Dec; 82-83():459-63. PubMed ID: 8597094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathy target esterase inhibitors: 2-alkyl-, 2-alkoxy-, and 2-(aryloxy)-4H-1,3,2-benzodioxaphosphorin 2-oxides.
    Wu SY; Casida JE
    Chem Res Toxicol; 1992; 5(5):680-4. PubMed ID: 1446009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An alternative in vitro method for detecting neuropathic compounds based on acetylcholinesterase inhibition and on inhibition and aging of neuropathy target esterase (NTE).
    Sogorb MA; González-González I; Pamies D; Vilanova E
    Toxicol In Vitro; 2010 Apr; 24(3):942-52. PubMed ID: 20097283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenyl valerate esterases other than neuropathy target esterase and the promotion of organophosphate polyneuropathy.
    Milatovic D; Moretto A; Osman KA; Lotti M
    Chem Res Toxicol; 1997 Sep; 10(9):1045-8. PubMed ID: 9305588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathy target esterase inhibition by organophosphorus esters in human neuroblastoma cells.
    Ehrich M; Correll L; Veronesi B
    Neurotoxicology; 1994; 15(2):309-13. PubMed ID: 7991219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postscript to the symposium on organophosphorus compound induced delayed neuropathy.
    Aldridge N
    Chem Biol Interact; 1993 Jun; 87(1-3):463-6. PubMed ID: 8344004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.